Ramos-Espiritu, Lavoisier
Kleinboelting, Silke
Navarrete, Felipe A
Alvau, Antonio
Visconti, Pablo E
Valsecchi, Federica
Starkov, Anatoly
Manfredi, Giovanni
Buck, Hannes
Adura, Carolina
Zippin, Jonathan H
van den Heuvel, Joop http://orcid.org/0000-0001-5085-4010
Glickman, J Fraser http://orcid.org/0000-0002-6706-4039
Steegborn, Clemens
Levin, Lonny R http://orcid.org/0000-0002-5204-6356
Buck, Jochen
Article History
Received: 30 December 2015
Accepted: 23 May 2016
First Online: 22 August 2016
Competing interests
: J.B., L.R.L. and J.H.Z. have equity interest in CEP Biotech, which has licensed commercialization of a panel of monoclonal antibodies directed against sAC.